Salmeterol Xinafoate

CAS 94749-08-3 17 current records 4 historicalSmall Molecule

Who holds supplier records for Salmeterol Xinafoate? 17 organisations hold a current record for Salmeterol Xinafoate: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 12 of them hold a valid EU Certificate of Suitability (13 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (7), China (2), Italy (2), Spain (1) and 3 other countries (3); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Salmeterol Xinafoate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/salmeterol-xinafoate

Reading the evidence

  • 17 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 8 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (17)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Salmeterol Xinafoate. Country is the organisation's recorded country, not necessarily the manufacturing site.

India7China2Italy2Spain1Macau1Finland1Portugal1Country not recorded for 2
Need Salmeterol Xinafoate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (13)

Certificates of Suitability on the EDQM register for Salmeterol Xinafoate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 17 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
NEULAND LABORATORIES LIMITED HyderabadIN
CEP 2011-277 - Rev 05
Salmeterol xinafoate
Jul 2026—
VAMSI LABS LIMITED SolapurIN
CEP 2006-226 - Rev 05
Salmeterol xinafoate, Non-micronised and micronised
Jul 2026—
FARMABIOS S.p.A Gropello CairoliIT
CEP 2018-168 - Rev 02
Salmeterol xinafoate
Jul 2026Inspected Jul 2026
Italy
MSN LABORATORIES PRIVATE LIMITED SangareddyIN
CEP 2018-261 - Rev 01
Salmeterol xinafoate, Route code XS
Jun 2026—
NATCO PHARMA LIMITED HyderabadIN
CEP 2009-013 - Rev 04
Salmeterol xinafoate
Jun 2026—
MELODY HEALTHCARE PRIVATE LIMITED MumbaiIN
CEP 2020-070 - Rev 03
Salmeterol xinafoate, Micronised
Mar 2026—
CIPLA LIMITED MumbaiIN
CEP 2006-296 - Rev 06
Salmeterol xinafoate, Micronised, grades I and II
Jan 2026—
INDUSTRIALE CHIMICA S.R.L. SaronnoIT
CEP 2013-107 - Rev 02
Salmeterol xinafoate
Oct 2025Inspected Oct 2025
Italy
AARTI PHARMALABS LIMITED Mulund (W), MumbaiIN
CEP 2008-239 - Rev 05
Salmeterol xinafoate, Micronised, non-micronised
Jun 2025—
HOVIONE FARMACIENCIA S.A. LouresPT
CEP 2018-057 - Rev 03
Salmeterol xinafoate, Process II
Mar 2024Inspected Apr 2025
Portugal
FERMION OY EspooFI
CEP 2018-044 - Rev 04
Salmeterol xinafoate, Micronised
Feb 2024Inspected Feb 2026
Finland
MSN LABORATORIES PRIVATE LIMITED Rudraram VillageIN
R1-CEP 2011-183 - Rev 00
Salmeterol xinafoate
Mar 2018—
INKE, S.A. CastellbisbalES
R1-CEP 2007-127 - Rev 00
Salmeterol xinafoate
Jun 2014—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Salmeterol Xinafoate are no longer active. These show a past filing, not current supply.

Show all 4 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Salmeterol Xinafoate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1082607).

Chemical identity

IUPAC name
2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol;1-hydroxynaphthalene-2-carboxylic acid
Canonical SMILES
C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O.C1=CC=C2C(=C1)C=CC(=C2O)C(=O)O
InChIKey
XTZNCVSCVHTPAI-UHFFFAOYSA-N
Synonyms
GR 33343 G, GR-33343 G, GR-33343X, LIPO-202, Salmeterol 1-hydroxy-2-naphthoate, Salmeterol xinafoate, Salmeterol xinafoate component of advair, Salmeterol xinafoate component of advair hfa, Salmeterol xinafoate component of airduo respiclick, Salmeterol xinafoate component of lipo-102, Serevent, Serevent diskus

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
beta2-Adrenergic Agonist
Mechanism of action
Adrenergic beta2-Agonists

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Salmeterol Xinafoate?

17 organisations hold an active US FDA Type II Drug Master File or a CEP for Salmeterol Xinafoate: AARTI PHARMALABS LIMITED (India), Cipla Limited (India), INKE SA (Spain), MELODY HEALTHCARE PVT LTD (India), MSN Laboratories Private Limited (India), Natco Pharma (India), Neuland Laboratories Limited (India) and Amphastar Nanjing Pharmaceuticals (China), and 9 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Salmeterol Xinafoate Drug Master Files are active?

AARTI PHARMALABS LIMITED (DMF 22054), Cipla Limited (DMF 18378, 15706), INKE SA (DMF 23914), MELODY HEALTHCARE PVT LTD (DMF 24040, 30387), MSN Laboratories Private Limited (DMF 31242, 24828), Natco Pharma (DMF 18394), Neuland Laboratories Limited (DMF 22973) and Amphastar Nanjing Pharmaceuticals (DMF 29491) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Salmeterol Xinafoate records mean?

4 organisations have only inactive Type II DMFs for Salmeterol Xinafoate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Salmeterol Xinafoate have a European Certificate of Suitability?

Yes. 12 organisations hold a valid CEP for Salmeterol Xinafoate on the EDQM register, including NEULAND LABORATORIES LIMITED Hyderabad (IN), VAMSI LABS LIMITED Solapur (IN), FARMABIOS S.p.A Gropello Cairoli (IT), MSN LABORATORIES PRIVATE LIMITED Sangareddy (IN), NATCO PHARMA LIMITED Hyderabad (IN) and MELODY HEALTHCARE PRIVATE LIMITED Mumbai (IN) and 7 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Salmeterol Xinafoate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Salmeterol Xinafoate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.